The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death

Chemico-Biological Interactions

Volumn 184, Issue 3, 2010, Pages 319-327

  Han, Yong Hwan ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; As4.1; GSH; MG132; ROS

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE 3; CASPASE 8; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL GROWTH; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; IC 50; JUXTAGLOMERULAR CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; BUTHIONINE SULFOXIMINE; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; DITIOCARB; ENZYME INHIBITORS; G1 PHASE; GLUTATHIONE; JUXTAGLOMERULAR APPARATUS; LEUPEPTINS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; POLY(ADP-RIBOSE) POLYMERASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 77949915298     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.01.033     Document Type: Article

References (33)

1. Gonzalez C., Sanz-Alfayate G., Agapito M.T., Gomez-Nino A., Rocher A., Obeso A. Significance of ROS in oxygen sensing in cell systems with sensitivity to physiological hypoxia. Respir. Physiol. Neurobiol. 2002, 132(1):17-41.
2. Baran C.P., Zeigler M.M., Tridandapani S., Marsh C.B. The role of ROS and RNS in regulating life and death of blood monocytes. Curr. Pharm. Des. 2004, 10(8):855-866.
3. Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial ROS-induced ROS release: an update and review. Biochim. Biophys. Acta 2006, 1757(5-6):509-517.
4. Wilcox C.S. Reactive oxygen species: roles in blood pressure and kidney function. Curr. Hypertens. Rep. 2002, 4(2):160-166.
5. Poot M., Teubert H., Rabinovitch P.S., Kavanagh T.J. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J. Cell. Physiol. 1995, 163(3):555-560.
6. Schnelldorfer T., Gansauge S., Gansauge F., Schlosser S., Beger H.G., Nussler A.K. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 2000, 89(7):1440-1447.
7. Lauterburg B.H. Analgesics and glutathione. Am. J. Ther. 2002, 9(3):225-233.
8. Dasmahapatra G., Rahmani M., Dent P., Grant S. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 2006, 107(1):232-240.
9. Wallach-Dayan S.B., Izbicki G., Cohen P.Y., Gerstl-Golan R., Fine A., Breuer R. Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290(4):L790-L796.
10. Shim H.Y., Park J.H., Paik H.D., Nah S.Y., Kim D.S., Han Y.S. Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK1/2-c-Jun activation. Mol. Cells 2007, 24(1):95-104.
11. Orlowski R.Z The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ. 1999, 6(4):303-313.
12. Voges D., Zwickl P., Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 1999, 68:1015-1068.
13. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998, 8(10):397-403.
14. Wu H.M., Chi K.H., Lin W.W. Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production. FEBS Lett. 2002, 526(1-3):101-105.
15. Perez-Galan P., Roue G., Villamor N., Montserrat E., Campo E., Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006, 107(1):257-264.
16. Ling Y.H., Liebes L., Zou Y., Perez-Soler R. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J. Biol. Chem. 2003, 278(36):33714-33723.
17. Qiu J.H, Asai A., Chi S., Saito N., Hamada H., Kirino T. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 2000, 20(1):259-265.
18. Sigmund C.D., Okuyama K., Ingelfinger J., Jones C.A., Mullins J.J., Kane C., Kim U., Wu C.Z., Kenny L., Rustum Y., et al. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J. Biol. Chem. 1990, 265(32):19916-19922.
19. Bailey H.H. L-S, R-buthionine sulfoximine: historical development and clinical issues. Chem. Biol. Interact. 1998, 111-112:239-254.
20. Cocco D., Calabrese L., Rigo A., Argese E., Rotilio G. Re-examination of the reaction of diethyldithiocarbamate with the copper of superoxide dismutase. J. Biol. Chem. 1981, 256(17):8983-8986.
21. Park W.H., Seol J.G., Kim E.S., Hyun J.M., Jung C.W., Lee C.C., Kim B.K., Lee Y.Y. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res. 2000, 60(11):3065-3071.
22. Han Y.H, Kim S.H., Kim S.Z., Park W.H. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int. J. Oncol. 2008, 33(5):1099-1105.
23. Han Y.H., Kim S.Z., Kim S.H., Park W.H. Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 2008, 59(3):301-314.
24. Han Y.H., Kim S.W., Kim S.H., Kim S.Z., Park W.H. 2,4-dinitrophenol induces G1 phase arrest and apoptosis in human pulmonary adenocarcinoma Calu-6 cells. Toxicol. In Vitro 2008, 22(3):659-670.
25. Han Y.H., Kim S.Z., Kim S.H., Park W.H. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am. J. Physiol. 2007, 293(2):F511-520.
26. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999, 6(2):99-104.
27. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281(5381):1305-1308.
28. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371(6495):346-347.
29. Jahngen-Hodge J., Obin M.S., Gong X., Shang F., Nowell T.R., Gong J., Abasi H., Blumberg J., Taylor A. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem. 1997, 272(45):28218-28226.
30. Lewis-Wambi J.S., Kim H.R., Wambi C., Patel R., Pyle J.R., Klein-Szanto A.J., Jordan V.C. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. Breast Cancer Res. 2008, 10(6):R104.
31. Ramos A.M., Aller P. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochem. Pharmacol. 2008, 75(10):1912-1923.
32. Han Y.H., Kim S.Z., Kim S.H., Park W.H. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine. Mol. Cells 2008, 26(2):158-164.
33. Han Y.H., Kim S.Z., Kim S.H., Park W.H. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine. Int. J. Oncol. 2008, 33(1):205-213.